Pillstats
OTC · Solution · Ophthalmic

Olopatadine Hydrochloride Ophthalmic Solution

Brands: Equate Olopatadine Hydrochloride Ophthalmic Solution · Leader Olopatadine Hydrochloride Ophthalmic Solution · Once Daily Relief · Olopatadine Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)135391
US makers6 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.357$0.714$1.07$1.43Dec 2025Apr 2026Jul 2026
$1.234
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
6
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7601.5K2.3K3.0K2025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
14K
Units dispensed
3
Quarters · since 2025 Q3

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch & Lomb Incorporatedunknown2SUPPLYING
Wal-Mart Stores, Inc.unknown1SUPPLYING
TARGET CORPORATIONunknown1SUPPLYING
H E Bunknown1SUPPLYING
WALGREEN COMPANYunknown1SUPPLYING
Cardinal Healthunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.